U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895681) titled 'UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations' on March 19.
Brief Summary: This is a non-therapeutic clinical research biorepository protocol designed to obtain, store, and clinically annotate biospecimens from participants with hereditary cancers. Those biospecimens will be used to generate participant-derived tumor models that will serve as a resource to better understand hereditary cancers and develop new efficient therapies.
Study Start Date: March 15
Study Type: OBSERVATIONAL
Condition:
Solid Tumor
Solid Tumor, Adult
Somatic Mutation
Solid Tumor, Unspecified, Adult
Hereditary Cancer
Intervention:
PRO...